2900 – 550 Burrard Street
Vancouver, BC V6C 0A3
Canada
https://filament.health
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Benjamin Lightburn | Co-Founder, CEO & Chairman | 126.77k | N/A | 1987 |
Mr. Tom Kineshanko | Co-Founder | 126.77k | N/A | 1985 |
Mr. Warren Duncan CPA | Chief Financial Officer | 108.66k | N/A | 1991 |
Mr. Jon Conlin | Corp. Sec. & Director | N/A | N/A | 1986 |
Ms. Lisa Ranken | Chief Operating Officer | N/A | N/A | 1984 |
Mr. Ryan Moss | Chief Science Officer | N/A | N/A | N/A |
Ms. Anna Cordon | Director of Communications | N/A | N/A | N/A |
Mr. Jeff Fellows | Head of Regulatory | N/A | N/A | N/A |
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.